Breast
Latest Articles
(BioPharma Reporter) Mar 22, 2017 - Amgen has signalled its intention to take a share of the $6.9bn Herceptin market by filing its trastuzumab candidate in the EU.
Read Article
(PharmaTimes [UK]) Mar 23, 2017 - The National Institute for Health and Care Excellence has now published updated familial breast cancer guidelines which advocate the use of three medicines to reduce the risk of developing the disease.
Read Article
More Articles
March 22, 2017
March 21, 2017
March 21, 2017
March 21, 2017
March 20, 2017
March 20, 2017
March 20, 2017
March 16, 2017
View More
News Commentary
Editor Image
10 Dec, 2016 | by Dean Gesme, MD
It is encouraging to see three competing CDK 4/6 inhibitors soon to be...
View Comment
Editor Image
15 Feb, 2017 | by William Harwin MD
At Florida Cancer Specialists we have been using DigniCap for several months at...
View Comment
View More
OBR Green
There are no Breast OBR Green articles.
OBR Blog
There are no Breast blog entries.